Commentary
In this commentary, the authors describe experiences to date with acquiring, storing, handling, administering and billing for long-acting cabotegravir and rilpivirine through four scenarios, each of which have presented their own unique obstacles and learning curves.
Original Research
The goal of this retrospective analysis is to assess changes in virological suppression, immunological status, renal function, weight and body mass index (BMI) amongst people living with HIV who switched from a tenofovir disoproxil fumarate-based to a tenofovir alafenamide-based regimen.
Original Research
The objectives of this study were to assess antiretroviral therapy and hormonal contraceptive use among women living with HIV and quantify the frequency of potential drug–drug interactions between antiretroviral therapy and hormonal contraceptives.
Review
This review discusses antiretroviral therapy and its nephrotoxic effects, including drug–drug interactions. It aims to guide the clinician on dose adjustment in the setting of renal impairment and dialysis, for the commonly used drugs in patients with HIV.
Review
This review summarizes chemical, pharmacological, and clinical information about doravirine with an emphasis on drug resistance. The efficacy results from an early phase clinical trial evaluating doravirine in combination with islatravir are also provided.
